Ç. BOZKURT GÜZEL Et Al. , "In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.," 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC) , Boston, United States Of America, pp.154, 2010
BOZKURT GÜZEL, Ç. Et Al. 2010. In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.. 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC) , (Boston, United States Of America), 154.
BOZKURT GÜZEL, Ç., B. Savage, P., & Gerceker, A., (2010). In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. . 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC) (pp.154). Boston, United States Of America
BOZKURT GÜZEL, Çağla, Paul B. Savage, And A.Alev Gerceker. "In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.," 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC), Boston, United States Of America, 2010
BOZKURT GÜZEL, Çağla B. Et Al. "In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.." 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC) , Boston, United States Of America, pp.154, 2010
BOZKURT GÜZEL, Ç. B. Savage, P. And Gerceker, A. (2010) . "In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.." 50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC) , Boston, United States Of America, p.154.
@conferencepaper{conferencepaper, author={Çağla BOZKURT GÜZEL Et Al. }, title={In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.}, congress name={50th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICAAC)}, city={Boston}, country={United States Of America}, year={2010}, pages={154} }